New hope for kids: shorter malaria cure tested in PNG
NCT ID NCT07403643
First seen Feb 16, 2026 · Last updated May 22, 2026 · Updated 18 times
Summary
This study tests the safety and effectiveness of tafenoquine, a single-dose medicine, for treating vivax malaria in 60 children in Papua New Guinea. Vivax malaria can hide in the liver and come back, so this treatment aims to clear both blood and liver parasites. The study will also check how the drug interacts with common malaria treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCOMPLICATED MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alexishafen Health Centre
Madang, Madang Province, MP511, Papua New Guinea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.